DCEP regimen
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Overview
DCEP regimen refers to a regimen consisting of Dexamethasone, cyclophosphamide, etoposide and cisplatin (DCEP) for relapsed or refractory multiple myeloma patients.[1]
Regimen
DDexamethasone
CCyclophosphamide
EEtoposide
PCisplatin
Indications
- Relapsed or refractory multiple myeloma[1]
References
- ↑ 1.0 1.1 Dadacaridou M, Papanicolaou X, Maltesas D, Megalakaki C, Patos P, Panteli K; et al. (2007). “Dexamethasone, cyclophosphamide, etoposide and cisplatin (DCEP) for relapsed or refractory multiple myeloma patients”. J BUON. 12 (1): 41–4. PMID 17436400.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH